Bi-ventricular Epicardial Activation in Left Bundle Area Pacing: a Comparison Study
LBBAP
1 other identifier
interventional
30
1 country
1
Brief Summary
Study of the ventricular activation patterns during left bundle area pacing and compare it with baseline activation during normal sinus rhythm in patients with and without baseline bundle branch conduction disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 24, 2022
CompletedFirst Submitted
Initial submission to the registry
April 4, 2022
CompletedFirst Posted
Study publicly available on registry
June 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2024
CompletedFebruary 28, 2024
May 1, 2023
1.9 years
April 4, 2022
February 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Epicardial map
Activation patterns (visual inspection) on non-invasive 3D ECG mapping
1 day
Epicardial map
Activation time (ms) on non-invasive 3D ECG mapping
1 day
Secondary Outcomes (2)
Echo parameters for resynchronization
90 days
Echo parameters for resynchronization
90 days
Study Arms (1)
Body surface mapping
OTHERWith the Insite Vest, activation of the epicardium will be performed.
Interventions
RV Lead will be placed deep in the interventricular septum
Eligibility Criteria
You may qualify if:
- patients with a functional LBB-AP pacemaker
You may not qualify if:
- Age \< 18 years
- Previous cardiac surgery
- Cardiomyopathy with documented ventricular scar
- Patients with prior pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Brussel
Brussels, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carlo De Asmundis, MD, PhD
UZ Brussels
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2022
First Posted
June 2, 2022
Study Start
March 24, 2022
Primary Completion
February 21, 2024
Study Completion
October 21, 2024
Last Updated
February 28, 2024
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share